MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹1,902 Cr | ₹1,991 Cr | ₹165 Cr | ₹14,447 Cr | ₹925 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
Year | Operating Profit |
---|---|
Mar2024 | ₹1,902 Cr |
Mar2023 | ₹1,991 Cr |
Mar2022 | ₹165 Cr |
Mar2021 | ₹14,447 Cr |
Mar2020 | ₹925 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,902 Cr | -4.45 | |
Mar2023 | ₹1,991 Cr | 1,107.04 | |
Mar2022 | ₹165 Cr | -98.86 | |
Mar2021 | ₹14,447 Cr | 1,461.81 | |
Mar2020 | ₹925 Cr | - |
Compare Operating Profit of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹101,363.4 Cr | 2.4% | 7.1% | 3.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 2.4% |
7.1% |
3.9% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses